ALNY vs AMSF · P/E 76, rev $1.29B vs P/E 18, rev $172.1M
Alnylam Pharmaceuticals Inc (ALNY) versus AMERISAFE Inc (AMSF) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
AMERISAFE Inc (AMSF) is a insurance - specialty company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported AMSF revenue for 2026-06-30 was $172.1M. Net income was $22.7M. AMSF currently screens at market cap $841.3M and trailing P/E 17.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. AMSF currently screens at market cap $841.3M and trailing P/E 17.8.
Not investment advice. Open the ALNY and AMSF stock pages for the full models.
Not investment advice.